Epilepsy - Pipeline Insight and Therapeutic Assessment, H2 2017
Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1297813
Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the brain which causes seizures. This leads to brief disruptions of the senses and short periods of unconsciousness or convulsions. Symptoms of epilepsy are repeated seizures, weakness, and anxiety, loss of consciousness and contraction, or jerking, of body muscles. Main causes of epilepsy include low oxygen during birth, head injuries that occur during birth or from accidents during youth or adulthood, brain tumors, genetic conditions that result in brain injury, such as tuberous sclerosis, infections such as meningitis or encephalitis, and stroke or any other type of damage to the brain.
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Epilepsy - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Epilepsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Epilepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 5, 12, 13, 21, 2, 85, 13 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 20 and 2 molecules, respectively.
Epilepsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
- The pipeline guide provides a snapshot of the global therapeutic landscape of Epilepsy (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Epilepsy (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Epilepsy (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Epilepsy (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Epilepsy (Central Nervous System)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Epilepsy (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Epilepsy (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Read Full Report with TOC: http://www.marketresearchhub.com/report/epilepsy-pipeline-review-h2-2017-report.html
Table of Contents:
Epilepsy - Overview 7
Epilepsy - Therapeutics Development 8
Epilepsy - Therapeutics Assessment 31
Epilepsy - Companies Involved in Therapeutics Development 45
Epilepsy - Drug Profiles 81
Epilepsy - Dormant Projects 382
Epilepsy - Discontinued Products 389
Epilepsy - Product Development Milestones 391
Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1297813
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
90 State Street,
Albany, NY 12207,
Toll Free: 1-800-998-4852 (US-Canada)
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epilepsy - Pipeline Insight and Therapeutic Assessment, H2 2017 here
News-ID: 673416 • Views: 161
More Releases from Healthcare Industry Market Report - MRH
Global Pressure Relief Mattress Market Analysis, Competitor Analysis, Choice Mod …
The global pressure relief mattress market is growing steadily at a CAGR of 4.63%, owing to rise in demand from individual end-users and healthcare providers, who are looking for better patient care services. Long-term bed-ridden patients in hospitals or in-home care and older adults are more prone to develop pressure ulcers due to lack of mobility. Growing demand for pressure relief mattress from such patients are driving the market growth. Request
Global Hearing Protection Devices Market Segmentation and Analysis by Market Res …
Hearing protection devices are used to protect the human ear from hearing loss due to occupational and other harmful noise. These products reduce noise exposure levels and the risk of hearing loss. These devices have been in existence since the early 1900s, but in the US, the use of these devices in offices and workshops was not controlled by law until 1971. Request A Free Sample Report- http://www.marketresearchhub.com/enquiry.php?type=S&repid=1320831 The Market Research
Global Healthcare Fabrics Sales Market Report : Share, Growth, Size, Trends and …
Market Research Hub (MRH) has recently added a new report to its vast online database. This research study is titled as “Global Healthcare Fabrics Sales Market Report” 2017 which presents an in-depth study about the production, consumption, market volume, revenue (million USD) and market share across different geographical regions. In this report, the global Healthcare Fabrics market is valued at USD XX million in 2016 and is expected to
Vacation Animal Health Market Analysis, Outlook and Forecast Report Until 2021
Market Research Hub (MRH) has included the latest Forecast report titled “Vacation Animal Health Market Industry Analysis & Outlook (2017-2021)”, to its vast database. The report provides a comprehensive analysis of the global animal health market and its major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in-depth. Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1318871 Animals, like humans, also suffer from diseases and hence require
More Releases for Epilepsy
Rising Instances of Pediatric Epilepsy to Pave Novel Growth Avenues in Epilepsy …
Owing to large scale prevalence of epilepsy cases, inclusive of pediatric epilepsy, the market for epilepsy drugs is likely to remain agile in the coming years. Prevalent amongst both male and female demographics alike, epilepsy is a critical condition that affects the brain both partially as well as in whole. Lucrative reimbursement policies, coupled with growing patient awareness about novel therapeutics are likely to reflect favorably on the growth curve
Epilepsy Diagnosis & Treatment Market Report - World | Statistics
Market Highlights: Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the arms and legs, and others are some of the common symptoms of the disease. Increasing prevalence of epilepsy is a major driver for the market. According to a
World Congress on Epilepsy and Neuronal Synchronization
Inculcate the latent knowledge in Epilepsy and Neuronal synchrony May 14, 2018: Pulsus Group, host of World Congress on Epilepsy and Neuronal Synchronization, the Conference that discusses the Advanced diagnosis of Epilepsy. Epilepsy 2018 slated during October 15- 16, 2015 at London, UK will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Neurology, Neuropsychiatry & Neuropathology fields across the world. The Epilepsy conference scientific
Epilepsy Therapeutic Pipeline Market Review, 2026
Summary Epilepsy is a brain disorder characterized by recurrent and unpredictable seizures that are caused by sudden, disorderly, and excessive neuronal activity in the brain. It is one of the most common neurological conditions globally. Epilepsy can start at any age and can be a life-long condition. It is diagnosed after a patient has suffered at least one epileptic seizure and is referred to a specialist, where a description of the
Epilepsy - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Epilepsy - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H2 2017, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape. Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the
H2 Epilepsy Market Pipeline Review 2017
"The Report Epilepsy - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H2 2017, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape. Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in